Thomasville National Bank’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,933
Closed -$252K 239
2024
Q4
$252K Buy
2,933
+1,028
+54% +$111K 0.02% 208
2024
Q3
$227K Sell
1,905
-105
-5% -$14K 0.02% 222
2024
Q2
$287K Hold
2,010
0.02% 199
2024
Q1
$258K Buy
+2,010
New +$239K 0.02% 208
2017
Q2
Sell
-153,336
Closed -$2.63M 253
2017
Q1
$2.63M Buy
+153,336
New +$2.67M 0.52% 49
2016
Q3
Sell
-156,478
Closed -$4.21M 120
2016
Q2
$4.21M Sell
156,478
-73,630
-32% -$2.02M 1.11% 31
2016
Q1
$6.23M Sell
230,108
-3,044
-1% -$81.6K 1.88% 17
2015
Q4
$6.77M Sell
233,152
-224
-0.1% -$6.2K 2.4% 15
2015
Q3
$6.33M Sell
233,376
-3,174
-1% -$89.9K 2.31% 10
2015
Q2
$6.47M Sell
236,550
-7,850
-3% -$221K 2.24% 9
2015
Q1
$6.52M Buy
244,400
+4,872
+2% +$112K 2.23% 10
2014
Q4
$5.07M Sell
239,528
-442
-0.2% -$9.87K 1.81% 21
2014
Q3
$5.71M Sell
239,970
-2,042
-0.8% -$47K 2.18% 16
2014
Q2
$5.59M Sell
242,012
-9,802
-4% -$216K 2.04% 16
2014
Q1
$5.75M Sell
251,814
-3,696
-1% -$78.7K 2.37% 13
2013
Q4
$4.72M Buy
255,510
+48,870
+24% +$852K 2.08% 17
2013
Q3
$3.5M Buy
+206,640
New +$3.48M 1.82% 22

Other funds holding NVO

Thomasville National Bank's NVO Position: Q1 2025 in Review

Thomasville National Bank sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,933 shares — an estimated $252K sold.

Thomasville National Bank first reported a position in NVO in Q3 2013 and held it in 17 quarters. The position peaked at $6.77M in Q4 2015. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Thomasville National Bank reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Thomasville National Bank sold 2,933 Novo Nordisk shares in Q1 2025, an estimated $252K.
  • Thomasville National Bank first reported a position in Novo Nordisk in Q3 2013 and held it in 17 quarters.
  • Thomasville National Bank's Novo Nordisk position peaked at $6.77M in Q4 2015.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Thomasville National Bank's 13F filing for Q1 2025, filed 16 Apr 2025.